Pacira Pharma (PCRX) Tops Q2 EPS by 20c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| PACIRA (NASDAQ: PCRX) | Delayed: 36.43 +0.04 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.39 | 52 Week High | $80.25 | |||
| Open | $36.41 | 52 Week Low | $30.25 | |||
| Day High | $36.45 | P/E | N/A | |||
| Day Low | $36.38 | EPS | $-2.08 | |||
| Volume | 1,827,369 | |||||
